Clinical Trial Update: Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A phase 3 clinical trial is evaluating the effectiveness of medium-dose cytarabine combined with venetoclax as consolidation therapy for elderly patients with i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Venclexta (venetoclax)

Snippet

Sponsor: Yehui Tan | Conditions: Acute Myeloid Leukemia (AML), Elderly | Phase 3 | Status: RECRUITING